Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Net Cash Flow Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 112.73 Mn | 84.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -18.60% |
| Jun 30, 2025 | -41.61% |
| Mar 31, 2025 | -35.18% |
| Dec 31, 2024 | 37.38% |
| Sep 30, 2024 | 25.28% |
| Jun 30, 2024 | 20.79% |
| Mar 31, 2024 | -62.05% |
| Dec 31, 2023 | 16.84% |
| Sep 30, 2023 | 18.35% |
| Jun 30, 2023 | 16.69% |
| Mar 31, 2023 | -25.97% |
| Dec 31, 2022 | -29.35% |
| Sep 30, 2022 | -15.67% |
| Jun 30, 2022 | -39.60% |
| Mar 31, 2022 | -1.16% |
| Dec 31, 2021 | -25.42% |
| Sep 30, 2021 | 18.64% |
| Jun 30, 2021 | -35.12% |
| Mar 31, 2021 | -48.00% |
| Dec 31, 2020 | 44.90% |